Monday, February 6, 2017

BRIEF-Medicinova announces positive findings from completed trial of MN-166 research

* Medicinova announces positive findings from completed

trial of MN-166 (ibudilast) in methamphetamine dependence

presented at the 50th winter conference on brain research

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)